EUVIMEDEUVIMED entdecken
Crossref

A Dual Stimuli‐Responsive Nanoplatform Loaded Pt IV ‐Triptolide Prodrug for Achieving Synergistic Therapy toward Breast Cancer

Kang Fang, Yanting Sun, Jingxian Yang, Xiaochun Hu, Mengyao Chen, Ruihao Li, Xinda Yang, Ting Fan, Junjie Wu, Xiaohan Tong, Chunyan Dong, Shuo Shi iD

Advanced Healthcare Materials · 2023-11 · 12 (28)

DOI: 10.1002/adhm.202301328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.07.2023. Verfasst von Kang Fang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Chemical Assessment and Sustainability, School of Chemical Science and Engineering. Department of Oncology, East Hospital …. Hauptthemen laut MEDLINE: Breast Neoplasms, Prodrugs, Diterpenes. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To strengthen the antitumor efficacy and avoid toxicity to normal cells of cisplatin and triptolide, herein, an acid and glutathione (GSH) dual‐controlled nanoplatform for enhanced cancer treatment through the synergy of both “1+1” apoptosis and “1+1” ferroptosis is designed. Remarkably, ZIF8 in response to tumor microenvironment enhances drug targeting and protects drugs from premature degradation. Meanwhile, the Pt IV center can be easily reduced to cisplatin because of the large amount of GSH, thus liberating the triptolide as the coordinated ligand. The released cisplatin and hemin in turn boost the tumor cell “1+1” apoptosis through chemotherapy and photodynamic therapy, respectively. Furthermore, GSH reduction through Pt IV weakens the activation of glutathione peroxidase 4 (GPX4) effectively. The released triptolide can inhibit the expressions of GSH by regulating nuclear factor E2 related factor 2 (Nrf2), further promoting membrane lipid peroxidation, thus “1+1” ferroptosis can be achieved. Both in vitro and in vivo results demonstrate that the nanosystem can not only perform superior specificity and therapeutic outcomes but also reduce the toxicity to normal cells/tissues of cisplatin and triptolide effectively. Overall, the prodrug‐based smart system provides an efficient therapeutic strategy for cancer treatment by virtue of the effect of enhanced “1+1” apoptosis and “1+1” ferroptosis therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsProdrugsDiterpenesHumansFemaleCisplatinCell Line, TumorTumor MicroenvironmentEpoxy CompoundsPhenanthrenes

Stichwörter der Autor:innen

drug deliveryferroptosisplatinum prodrugsynergistic therapytriptolide

Substanzen

CisplatinProdrugsDiterpenestriptolideEpoxy CompoundsPhenanthrenes

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Chemical Assessment and Sustainability, School of Chemical Science and Engineering. Department of Oncology, East Hospital Affiliated to Tongji University, School of Medicine, Tongji University…
  • School of Medicine, Shanghai University, Shanghai, 200444, China.

ORCID-Profile: Shuo Shi

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Fang, K., Sun, Y., Yang, J., Hu, X., Chen, M., Li, R., Yang, X., Fan, T., Wu, J., Tong, X., Dong, C., & Shi, S. (2023). A Dual Stimuli‐Responsive Nanoplatform Loaded Pt IV ‐Triptolide Prodrug for Achieving Synergistic Therapy toward Breast Cancer. Advanced Healthcare Materials, 12(28). https://doi.org/10.1002/adhm.202301328

Vancouver

Fang K, Sun Y, Yang J, Hu X, Chen M, Li R, et al. A Dual Stimuli‐Responsive Nanoplatform Loaded Pt IV ‐Triptolide Prodrug for Achieving Synergistic Therapy toward Breast Cancer. Advanced Healthcare Materials. 2023;12(28). doi:10.1002/adhm.202301328

BibTeX
@article{Fang2023,
  author = {Fang, Kang and Sun, Yanting and Yang, Jingxian and Hu, Xiaochun and Chen, Mengyao and Li, Ruihao and Yang, Xinda and Fan, Ting and Wu, Junjie and Tong, Xiaohan and Dong, Chunyan and Shi, Shuo},
  title = {A Dual Stimuli‐Responsive Nanoplatform Loaded Pt IV ‐Triptolide Prodrug for Achieving Synergistic Therapy toward Breast Cancer},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {28},
  doi = {10.1002/adhm.202301328}
}
Kostenlos starten →